LEAP THERAPEUTIC

LPTX NASDAQ
1.905
-0.015
-0.78%
交易中 14:07 07/23 EDT
开盘
1.940
昨收
1.920
最高
1.965
最低
1.870
成交量
22.73万
成交均量(3M)
21.20万
52周最高
8.75
52周最低
1.350
换手率
0.99%
市值
4,392.43万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供LEAP THERAPEUTIC LPTX股票价格,LEAP THERAPEUTIC股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Leap Therapeutics, Inc., formerly HealthCare Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The Company engages in acquiring and developing therapeutics in cancer biology. Its lead product candidates for use in clinical trials include TRX518 and DKN-01. DKN-01 is a monoclonal antibody targeting Dickkopf-related protein 1 (DKK1). TRX518 is a monoclonal antibody targeting the glucocorticoid-induced tumor necrosis factor-related receptor (GITR). DKN-01 has potential as a targeted cancer treatment in esophageal cancer, cholangiocarcinoma, non-small cell lung cancer, and other tumor types, such as pancreatic, gastric, liver, head and neck, uterine, and prostate cancers and multiple myeloma. It is conducting two clinical trials of TRX518 in patients with advanced solid tumors and have evidence of biomarker modulation and clinical activity. DKN-01 has been tested in a pilot study in patients with multiple myeloma in combination with lenalidomide and dexamethasone. .
展开 >

最近浏览

名称
价格
涨跌幅